The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension drug.

UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was overcharging cancer patients by 1000%.

Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.

From 2017 to 2022, the companies — UnitedHealth Group's UNH.N Optum ... of the acquisition costs of the drugs, the FTC said in its second report on the industry. "The $7.3 billion is ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth ... a year” and said the FTC had failed to address the underlying causes of rising drug prices. UnitedHealth’s Optum ...

Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth Group Inc ... according to a new interim staff report. FTC said the "Big 3 PBMs" — CVS’s Caremark ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

CVS Health, UnitedHealth Group and Cigna share prices dipped midday after the FTC released its report, but each company rebounded and was up slightly when the New York Stock Exchange closed Tuesday.

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group ... spend on medications in a year” and said the FTC had failed to address the underlying causes of rising drug prices.